KR20180063390A - Method for Preparing Mulberry Leaf Extracts - Google Patents

Method for Preparing Mulberry Leaf Extracts Download PDF

Info

Publication number
KR20180063390A
KR20180063390A KR1020160157981A KR20160157981A KR20180063390A KR 20180063390 A KR20180063390 A KR 20180063390A KR 1020160157981 A KR1020160157981 A KR 1020160157981A KR 20160157981 A KR20160157981 A KR 20160157981A KR 20180063390 A KR20180063390 A KR 20180063390A
Authority
KR
South Korea
Prior art keywords
mixture
extract
powder
drying
hours
Prior art date
Application number
KR1020160157981A
Other languages
Korean (ko)
Other versions
KR101894994B1 (en
Inventor
송윤석
이승제
이양수
채수완
강성선
Original Assignee
부안군(관리부서: 부안군 농업기술센터)
전북대학교산학협력단
재단법인 전라북도생물산업진흥원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 부안군(관리부서: 부안군 농업기술센터), 전북대학교산학협력단, 재단법인 전라북도생물산업진흥원 filed Critical 부안군(관리부서: 부안군 농업기술센터)
Priority to KR1020160157981A priority Critical patent/KR101894994B1/en
Publication of KR20180063390A publication Critical patent/KR20180063390A/en
Application granted granted Critical
Publication of KR101894994B1 publication Critical patent/KR101894994B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/20Agglomerating; Granulating; Tabletting
    • A23P10/28Tabletting; Making food bars by compression of a dry powdered mixture
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/3262Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A method for producing Morus alba extracts provides a materialization process in which functional materials contained in Morus alba are efficiently extracted to develop functional food materials for blood sugar control and blood circulation improvement, and there is an effect that the Morus alba extracts can be developed as health functional food materials for blood sugar control, blood circulation improvement, arteriosclerosis and the like by efficiently extracting the functional material contained in the Morus alba.

Description

상엽 추출물 제조 방법{Method for Preparing Mulberry Leaf Extracts}Method for Preparing Mulberry Leaf Extracts [

본 발명은 상엽 추출물 제조 방법에 관한 것으로서, 특히 상엽에 함유된 기능성 물질을 효율적으로 추출하여 혈당 조절 및 혈행 개선의 기능성 식품 소재로 개발하기 위한 소재화 공정을 제공하는 상엽 추출물 제조 방법에 관한 것이다.The present invention relates to a method for preparing a leaf extract, and more particularly, to a method for producing a leaf extract, which provides a materialization process for efficiently extracting a functional material contained in a leaf, thereby developing a functional food material for controlling blood glucose and improving blood circulation.

동의보감에는 뽕잎(mulberry leaves)이 각기병, 부종, 당뇨 및 탈항 등의 효과를 갖는 약용식물로 기록되어 있다. 최근 우리나라를 비롯한 중국, 일본 등에서 당뇨 및 혈중 콜레스테롤 저하 등의 성인병을 예방 및 치료하는 뽕잎의 효과가 밝혀지면서 기능성 식품의 재료로서 각광받고 있다.Mulberry leaves are recorded as medicinal plants with effects such as angelic disease, edema, diabetes and decolorization. Recently, the effect of mulberry leaves to prevent and treat adult diseases such as diabetes and blood cholesterol lowering has been recognized as a material of functional foods in Korea, China, and Japan.

뽕나무에는 25종의 아미노산이 함유되어 있으며 알라닌, 아스파르트산 및 글루탐산의 함량이 많아서 숙취를 없애주는 것으로 알려져 있다. 또한 세린과 티로신이 함유되어 있어 뇌의 혈액 순환과 노인성 치매를 예방해 주며, 상엽(뽕잎)에 함유된 각종 미네랄의 함량을 녹차와 비교해 볼 때 칼슘은 6배, 철분은 2배, 칼륨은 1.4배 높은 것으로 보고되고 있다.Mulberry contains 25 kinds of amino acids, and is known to eliminate hangover because of the high contents of alanine, aspartic acid and glutamic acid. It also contains serine and tyrosine to prevent blood circulation and senile dementia in the brain. Compared to green tea, the content of various minerals contained in mulberry leaves is 6 times that of calcium, 2 times of iron, 1.4 times of potassium It is reported to be high.

그러나 지금까지 개발된 제품은 상옆으로부터 추출물을 단순히 즙 형태로 추출하고 그 추출된 즙에 단순히 알코올을 첨가하여 숙성시키거나 단순히 상엽즙에 물과 기타 감미료를 혼합하여 제조한 것으로 다른 음료에 비하여 상대적으로 풍미감과 감칠맛이 떨어져 그 수요가 미미하다는 문제가 있다.However, the products developed so far are those obtained by simply extracting the extract from the upper side and adding the alcohol to the extracted juice, or merely mixing the juice with the water and the other sweeteners, There is a problem that the demand is small due to the difference in flavor and richness.

이와 같은 문제점을 해결하기 위하여, 본 발명은 상엽에 함유된 기능성 물질을 효율적으로 추출하여 혈당 조절 및 혈행 개선의 기능성 식품 소재로 개발하기 위한 소재화 공정을 제공하는 상엽 추출물 제조 방법을 제공하는데 그 목적이 있다.In order to solve such problems, the present invention provides a method for preparing a leaf extract for providing a materializing process for efficiently extracting a functional material contained in a leaf, thereby developing a functional food material for controlling blood glucose and improving circulation, .

상기 목적을 달성하기 위한 본 발명의 특징에 따른 상엽 추출물 제조 방법은,According to an aspect of the present invention,

추출기에 물 70 리터를 넣고 50℃로 가열하는 단계;Adding 70 liters of water to the extractor and heating to 50 캜;

일정량의 건조된 상엽을 추출포에 넣고 추출기에 투입하여 50℃에서 4시간 동안 추출하고 1㎛ 여과막에서 여과시키는 단계;A predetermined amount of dried top leaves are put into an extracting bag, put into an extractor, extracted at 50 ° C for 4 hours, and filtered through a 1 μm filter membrane;

감압농축기에서 60℃의 온도로 6배 부피가 감소하게 감압 농축하는 단계;Concentrated under reduced pressure in a vacuum concentrator at a temperature of 60 DEG C to reduce the volume by 6 times;

살균기에서 상엽 추출물농축액을 80℃에서 30분간 살균하는 단계; 및Sterilizing the leaf extract concentrate in a sterilizer at 80 DEG C for 30 minutes; And

상기 추출한 상엽 추출물농축액을 일정 조건의 진공 하에서 동결 건조하거나 일정 온도에서 분무 건조하는 단계를 포함한다.And lyophilizing the extract of the extracted leaf extracts under vacuum at a predetermined condition or spray drying the extract at a predetermined temperature.

상기 진공 하에서 동결 건조하거나 일정 온도에서 분무 건조하는 단계는,The step of freeze-drying under vacuum or spray-drying at a predetermined temperature may be carried out,

상기 동결 건조 단계에 있어서는, 상기 상엽 추출물농축액내 고형분 함량을 기준으로 상기 상엽 추출물농축액 내 고형분 함량 대비 말토덱스트린 함량을 8:2로 배합하여 -40℃, 600 mTorr 이하의 진공 하에서 72시간 동안 동결 건조하고,In the lyophilization step, maltodextrin content was adjusted to 8: 2 based on the solid content in the concentrate of the leaf extract, based on the solid content of the leaf extract, and the mixture was freeze-dried at -40 ° C. under a vacuum of 600 mTorr or less for 72 hours and,

상기 분무 건조 단계에 있어서는, 상기 상엽 추출물농축액 내 고형분 함량을 기준으로 상기 상엽 추출물농축액 내 고형분 함량 대비 말토덱스트린 함량을 8:2로 배합하여 240℃에서 분무 건조하는 것을 특징으로 한다.In the spray drying step, the content of maltodextrin is adjusted to 8: 2 by weight based on the solid content in the concentrated liquid of the upper leaf extract, and spray dried at 240 ° C.

본 발명의 특징에 따른 상엽 추출물 제조 방법은,The method for producing the leaf extract of the present invention,

건조 분쇄한 인삼 분말과 상엽을 1 : 1 내지 3 중량비로 혼합한 혼합물을 추출기에 투입하여 50℃에서 3시간 동안 추출하고 1㎛ 여과막에서 여과시키는 단계;Mixing the dried and ground ginseng powder with the upper leaves at a weight ratio of 1: 1 to 3: 3, and extracting the mixture at 50 ° C for 3 hours and filtering through a 1 μm filter membrane;

감압농축기에서 60℃의 온도로 5배 부피가 감소하게 감압 농축하는 단계; 및Concentrated under reduced pressure in a vacuum concentrator at a temperature of 60 ° C to reduce the volume by 5 times; And

살균기에서 추출물농축액을 80℃에서 30분간 살균시키는 단계를 포함한다.Sterilizing the extract concentrate in a sterilizer at 80 DEG C for 30 minutes.

상기 살균하는 단계 이후에,After the sterilization step,

상기 추출물농축액을 -40℃, 60mTorr 이하의 진공 하에서 72시간 동안 동결 건조시킨 후 분쇄하여 약리분말을 얻는 단계;Lyophilizing the extract concentrate for 72 hours under a vacuum of -40 DEG C, 60 mTorr or less, and pulverizing the extract to obtain a pharmacological powder;

오미자를 건조 및 분쇄하여 오미자 분말의 증량제를 얻는 단계;Drying and crushing the omiza to obtain an extender of the omija powder;

상기 약리분말과 오미자 분말의 혼합물을 환으로 뭉치거나, 약용캡슐 내에 캡슐레이션하거나 환으로 뭉친 후 그 외면에 약용피막을 입히는 단계를 더 포함한다.The method may further comprise the step of aggregating the mixture of the pharmacologically and omisina powders with a ring, encapsulating in a capsule for medicines or a ring, and applying a medicinal coating on the outer surface.

상기 감압 농축하는 단계 이후에,After the step of concentration under reduced pressure,

상기 감압 농축된 추출물농축액과 오미자 분말을 1:0.5 내지 1 중량비로 혼합하여 혼합물을 생성하는 단계;Mixing the extract concentrate with the reduced-pressure concentrated extract and Omija powder at a weight ratio of 1: 0.5 to 1 to produce a mixture;

상기 혼합물과 설탕을 1:0.5 내지 1 중량비로 혼합한 후, 24시간 동안 저어주면서 산을 추출하고 일정 시간 1 내지 10회 섞어준 후 여과하는 단계;Mixing the mixture with the sugar at a weight ratio of 1: 0.5 to 1, then extracting the acid with stirring for 24 hours, mixing the mixture for 1 to 10 times, and then filtering the mixture;

살균기에서 상기 추출물농축액을 60 내지 70℃에서 30분간 중탕하여 살균시키는 단계를 더 포함한다.Sterilizing the extract concentrate in a sterilizer at 60 to 70 DEG C for 30 minutes by soaking.

전술한 구성에 의하여, 본 발명은 상엽에 함유된 기능성 물질을 효율적으로 추출하여 혈당 조절, 혈행 개선, 동맥 경화 등 건강기능식품 소재로 개발할 수 있는 효과가 있다.According to the above-described constitution, the present invention has the effect of efficiently extracting the functional substance contained in the upper leaves and developing it as a health functional food material such as blood glucose control, blood circulation improvement, arteriosclerosis and the like.

본 발명은 상엽에 함유된 기능성 물질을 효율적으로 추출하여 기능성 식품의 제품화를 구현하여 건강한 먹거리와 건강 지향적인 식품을 제공할 수 있는 효과가 있다.The present invention has the effect of providing a healthy food and a health-oriented food by efficiently extracting the functional material contained in the upper leaves to realize the commercialization of the functional food.

도 1은 본 발명의 제1 실시예에 따른 상엽 추출물 제조 방법을 나타낸 도면이다.
도 2는 발명의 제2 실시예에 따른 상엽 추출물 제조 방법을 나타낸 도면이다.
FIG. 1 is a view illustrating a method for preparing a leaf extract according to a first embodiment of the present invention.
FIG. 2 is a view showing a method for manufacturing a leaf extract according to a second embodiment of the present invention.

명세서 전체에서, 어떤 부분이 어떤 구성요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있는 것을 의미한다.Throughout the specification, when an element is referred to as "comprising ", it means that it can include other elements as well, without excluding other elements unless specifically stated otherwise.

도 1은 본 발명의 제1 실시예에 따른 상엽 추출물 제조 방법을 나타낸 도면이다.FIG. 1 is a view illustrating a method for preparing a leaf extract according to a first embodiment of the present invention.

본 발명의 제1 실시예에 따른 상엽 추출물 제조 방법은 일정량의 건조된 상엽을 추출 후 농축하여 상엽 추출물농축액을 생성하는 단계(S100)와, 상엽 추출물농축액을 살균하고 일정 조건의 진공 하에서 동결 건조하거나 일정 온도에서 분무 건조하는 단계(S110)를 포함한다.The method for preparing a leaf extract according to the first embodiment of the present invention comprises the steps of extracting a predetermined amount of dried leaf and concentrating to produce a leaf extract concentrate (S100), sterilizing the leaf extract concentrate and freeze- And spray drying (S110) at a constant temperature.

구체적으로, 상엽 추출물농축액을 생성하는 단계(S100)는 추출기에 물 70 리터를 넣고 50℃로 가열하는 단계(S102)와, 건조된 상엽 3.5kg을 추출포에 넣고 추출기에 투입하여 50℃에서 4시간 동안 추출하는 단계(S104)와, 1㎛ 여과막에서 여과시키는 단계(S104)와, 감압농축기에서 60℃의 온도로 6배 부피가 감소하게 감압 농축하는 단계(S106)와, 살균기에서 상엽 추출물농축액을 80℃에서 30분간 살균하는 단계(S108)를 포함한다.More specifically, the step (S100) of producing a leaf extract concentrate is a step (S102) of placing 70 liters of water in an extractor and heating to 50 DEG C, and 3.5 kg of the dried top leaves are put in an extractor, (S104), a step (S104) of filtering through a 1 mu m filtration membrane, a step (S106) of concentrating the filtrate under reduced pressure at a temperature of 60 DEG C at a temperature of 60 DEG C by reducing the volume by 6 times, 0.0 > 80 C < / RTI > for 30 minutes (S108).

구체적으로, 상기 진공 하에서 동결 건조하거나 일정 온도에서 분무 건조하는 단계(S110)는, 상기 동결 건조 단계에 있어서는, 상기 상엽 추출물농축액 내 고형분 함량을 기준으로 상엽 추출물농축액 내 고형분 함량 대비 말토덱스트린 함량을 8:2로 배합하여 -40℃, 600 mTorr 이하의 진공 하에서 72시간 동안 동결 건조하고, 상기 분무 건조 단계에 있어서는, 상기 상엽 추출물농축액 내 고형분 함량을 기준으로 상엽 추출물농축액 내 고형분 함량 대비 말토덱스트린 함량을 8:2로 배합하여 240℃에서 분무 건조하는 것을 특징으로 한다.Specifically, the step (S110) of lyophilizing under vacuum or spray drying at a constant temperature may comprise, in the lyophilization step, the maltodextrin content to the solid content of the leaf extract in a concentration of 8 : 2, and lyophilized at -40 ° C. under a vacuum of 600 mTorr or less for 72 hours. In the spray drying step, the content of maltodextrin relative to the solid content in the leaf extract concentrate was determined on the basis of the solid content in the concentrate of the leaf extract 8: 2, and spray-dried at 240 ° C.

상엽(Mulberry leaves, Mori folium)은 상과에 속한 낙엽고목인 뽕나무(Moris alba L.) 동속 근연식물(뽕나무과 Moraceae)의 잎을 건조한 것으로, 한방에서 양혈조습(피의 열을 없애고 수분을 줄여 줌), 거풍명목(풍기운을 없애고 눈을 맑게 해 줌), 말복 지도한(분말로 복용하면 식은 땀을 없앰) 등의 효과가 있는 것으로 알려져 있다.Mulberry leaves (Mori folium) is a dried leaf of Moraceae (Moraceae) which is a deciduous tree belonging to the upper part of the family Moris alba L., , The name of a fierce wind (to remove wind energy and clear the eyes), and to tell the effect (such as taking the powder sweating).

상엽은 소장에서 탄수화물의 소화에 관여하는 효소인 α-glucosidase 활성을 억제하며, 그 혈당강하 활성을 식후 혈당 조절과 관련 있는 것으로 알려져 있다.It is known that the leaflet suppresses the activity of α-glucosidase, an enzyme involved in the digestion of carbohydrates in the small intestine, and its hypoglycemic activity is known to be related to postprandial glucose control.

상엽은 항당뇨, 항산화, 항염증 및 항고지혈증 등의 여러 생리적 작용을 지니고 있을 뿐만 아니라 플라보노이드(Flavonoids), 스틸벤(Stilbenes), 프레닐플라보노이드(Prenylflavonoids), 쿠마린(Coumarin) 및 디옥시노이지리마이신(Deoxynoijirimycine) 등의 등의 약리활성 성분을 다량 함유하고 있다. 또한 항산화, 항간독성 및 항당뇨성 생리활성물질을 함유하고 있어 기능성 식품의 소재로써 크게 각광을 받고 있다.In addition to having diverse physiological functions such as antidiabetic, antioxidant, anti-inflammatory and anti-hyperlipidemic effects, the upper leaves are also effective in the treatment of various diseases such as Flavonoids, Stilbenes, Prenylflavonoids, Coumarin and Deoxynojirimycin (Deoxynoijirimycine) and the like. Also, it contains antioxidant, antitumor toxin and antidiabetic biologically active substance, and it has been widely attracted as a material of functional food.

이 중 식후 혈당 상승을 억제하는 물질인 1-디옥시노이지리마이신(Deoxynoijirimycine)을 분석하면 다음과 같다.Among these, 1-deoxynoijirimycin, which is a substance that inhibits postprandial increase of blood glucose, is analyzed as follows.

1-Deoxynojirimycin 함량은 HPLC를 이용하여 분석하였다.1-Deoxynojirimycin content was analyzed by HPLC.

시험용액 10μL에 0.4M Potassium Borate Buffer (pH 8.5) 10μL와 10mM 9-flurenylmethyl chloroformate(FMOC-Cl) 20μL를 넣고 20℃에서 20분간 반응시켰다. 그 후에 0.1M glycine 10μL를 첨가해 반응을 종결 시킨 후 0.1% acetic acid 950 μL를 첨가한 다음 0.22μm Syringe Filter로 여과하여 HPLC로 분석하였다.10 μL of 0.4 M Potassium Borate Buffer (pH 8.5) and 20 μL of 10 mM 9-fluorenylmethyl chloroformate (FMOC-Cl) were added to 10 μL of the test solution and reacted at 20 ° C. for 20 minutes. Then, 10 μL of 0.1 M glycine was added to terminate the reaction. 950 μL of 0.1% acetic acid was added thereto, followed by filtration with a 0.22 μm syringe filter and analyzed by HPLC.

사용한 표준물질(1-Deoxynojirimycin)의 농도는 200 ppm, 100 ppm, 50 ppm, 25 ppm, 12.5 ppm이었다.The concentration of 1-Deoxynojirimycin used was 200 ppm, 100 ppm, 50 ppm, 25 ppm, and 12.5 ppm.

1-디옥시노이지리마이신를 분석하는 조건은 다음의 [표 1]과 같다.Conditions for analyzing 1-deoxyenojirimycin are shown in the following [Table 1].

Figure pat00001
Figure pat00001

상엽 추출액의 특성 분석은 당도 1.9°Brix이고, 상엽 추출물농축액의 당도는 10.4°Brix이다.The analysis of the characteristics of the leaf extracts showed that the sugar content was 1.9 ° Brix and the sugar content of the leaf extract was 10.4 ° Brix.

동결 건조 분말시료의 지표 성분 함량은 1-Deoxynojirimycin(DNJ) 함량이 95.39mg/100g이며, 분무 건조 분말시료의 지표 성분 함량은 1-Deoxynojirimycin(DNJ) 함량이 86.03mg/100g을 나타낸다.The concentration of 1-Deoxynojirimycin (DNJ) was 95.39mg / 100g, and the content of 1-Deoxynojirimycin (DNJ) was 86.03mg / 100g in the spray-dried powder samples.

도 2는 발명의 제2 실시예에 따른 상엽 추출물 제조 방법을 나타낸 도면이다.FIG. 2 is a view illustrating a method for manufacturing a leaf extract according to a second embodiment of the present invention.

본 발명의 제2 실시예에 따른 상엽 추출물 제조 방법은 건조 분쇄한 인삼 분말과 상엽을 1 : 1 내지 3 중량비로 혼합한 혼합물을 추출기에 투입하여 50℃에서 3시간 동안 추출하는 단계(S200)와, 1㎛ 여과막에서 여과시키는 단계(S202)와, 감압농축기에서 60℃의 온도로 5배 부피가 감소하게 감압 농축하는 단계(S204)와, 살균기에서 추출물농축액을 80℃에서 30분간 살균시키는 단계(S206)를 포함한다.The method for preparing the topical extract according to the second embodiment of the present invention comprises the step of injecting a mixture obtained by mixing the dried and ground ginseng powder and the topsheet at a weight ratio of 1: 1 to 3: 3 into the extractor and extracting the mixture at 50 ° C for 3 hours (S200) (S202), a step (S204) of reducing the volume by 5 times at a temperature of 60 ° C in a reduced pressure concentrator (S204), sterilizing the extract concentrate in a sterilizer for 30 minutes at 80 ° C S206).

다른 실시예로서, 살균하는 단계(S206) 이후에, 농축액을 -40℃, 60mTorr 이하의 진공 하에서 72시간 동안 동결 건조시킨 후 분쇄하여 약리분말을 얻는 단계와, 오미자를 건조 및 분쇄하여 오미자 분말의 증량제를 얻는 단계와, 상기 약리분말과 오미자 분말의 혼합물을 환으로 뭉치거나, 약용캡슐 내에 캡슐레이션하거나 환으로 뭉친 후 그 외면에 약용피막을 입히는 단계를 더 포함할 수 있다.In another embodiment, after the step of sterilizing (S206), the concentrate is lyophilized for 72 hours under vacuum at -40 DEG C, 60 mTorr or lower and then pulverized to obtain pharmacological powder; and the step of drying and pulverizing the omiza powder A step of obtaining an extender, and a step of clumping a mixture of the pharmacological powder and the omega powder into a ring, encapsulating the same in a medicinal capsule or a ring, and applying a medicinal coating on the outer surface of the medicinal powder.

오미자(五味子, Schizandrae Fructus)는 낙엽 활엽 덩굴나무로 잎은 어긋나고 난형(卵形) 또는 도란형(倒卵形)이며 끝은 급히 뾰족하고 톱니가 있으며 뒷면 맥상에 다소 털이 있다. 꽃은 홍백색으로 6~7월에 피며 자웅이주이다.Schizandrae Fructus is a deciduous broad-leaved vine, with alternate leaves, ovate or obovate, with sharp tips, sharp teeth, and slightly hairs on the back side. The flower is reddish white, bloomed in June-July, and it is migratory.

과실은 식용으로 쓰이고 가지 끝에 이삭모양으로 늘어지며 8~9월에 붉게 익는다. 과실을 오미자(오매자), 북오미자(SchizandraeFructus)라고 한다. 표고 200~1,600m 지리산, 전북, 강원도가 주산지이며 충남, 충북을 제외한 전국에 야생하고, 지리적으로 일본, 사할린, 만주, 중국에 분포한다.Fruit is used for food, hangs in the shape of a spike at the end of the branch, and ripens red from August to September. The fruit is called Schizandrae Fructus and Schizandrae Fructus. 200 ~ 1,600 m above sea level. It is the main province of Jirisan, Jeonbuk and Gangwon provinces. It is wild throughout the country except Chungnam and Chungbuk, and is distributed geographically in Japan, Sakhalin, Manchuria and China.

과실에는 시잔드롤(Schizandrol), 시잔드린(Schizandrin) A, B, C, 안질로일고미신(angeloylgomisin) O, P, 에피고미신 (epigomisin), 프레고모이신(pregomoisin), 데옥시시잔드린(Deoxyschizandrin) 등을 함유한다. 오미자는 오래전부터 수렴, 자양, 강장, 진해약, 해주독, 목마름, 수렴고삽, 익기생진, 보신염심 등의 약효를 가져 생약원료로 한방에서 사용해오던 재료이며, 오미자주의 원료로 오래전부터 사용하여 체내 섭취에 따른 인체 안정성이 이미 확인되어 있다.Fruits include Schizandrol, Schizandrin A, B, C, angeloylgomisin O, P, epigomisin, pregomoisin, deoxyschizandrin ) And the like. Omija has long been used as a raw material for medicinal herbs because of its medicinal properties such as astringency, nourishment, tenderness, astringency, ginger poison, thirst, astringency, Human stability due to ingestion has already been confirmed.

또 다른 실시예로서, 감압 농축하는 단계(S204) 이후에, 감압 농축된 농축액과 오미자 분말을 1:0.5 내지 1 중량비로 혼합하여 혼합물을 생성하는 단계와, 상기 혼합물과 설탕을 1:0.5 내지 1 중량비로 혼합한 후, 24시간 동안 저어주면서 산을 추출하고 일정 시간 1 내지 10회 섞어준 후 여과하는 단계와, 60 내지 70℃에서 30분간 중탕하여 살균시키는 단계를 포함한다.As another embodiment, there is provided a method for producing a mixture, comprising the steps of: (S204) a step of mixing and concentrating a concentrate under reduced pressure and an omija powder at a weight ratio of 1: 0.5 to 1; Mixing the mixture at a weight ratio, stirring the mixture for 24 hours, extracting the acid, mixing the mixture for 1 to 10 times for a certain period of time, filtering the mixture, and sterilizing the mixture by stirring at 60 to 70 캜 for 30 minutes.

인삼은 식품 분류학상 오가피의 인삼 속에 속하는 다년생 숙근초로서 지금까지 콜레스테롤 저하, 혈압 강하, 혈류 증가, 항산화 작용, 항노화 작용, 항암제 등의 활성을 가지고 있는 것으로 알려져 있다.Ginseng is a perennial herbaceous ginseng belonging to the ginseng group of ginseng in the food classification system. It has been known to have activities such as cholesterol lowering, blood pressure lowering, blood flow increase, antioxidant action, anti-aging action and anticancer drug.

인삼과 상엽의 혼합 비율은 대략 일 대 일 비율로 혼합할 때 1-Deoxynojirimycin(DNJ) 함량이 100mg/100g 이상으로 최대치를 나타낼 수 있어 혈당 강하용 기능성 식품이 될 수 있다.The mixing ratio of ginseng and upturned leaves can be maximized with 1-Deoxynojirimycin (DNJ) content of 100mg / 100g or more when mixed at a one-to-one ratio and can be a functional food for hypoglycemia.

또 다른 실시예로서, 상엽 추출물 제조 방법은 건조 분쇄한 상엽 분말과 오미자 분말을 일정 비율로 혼합한 혼합물을 50 내지 60℃의 열수에 일정 시간 담궈 열수추출액인 상엽 및 오미자 혼합 추출물을 얻는 단계와, 인삼 추출분말에 정제수를 첨가하여 인삼 용액을 제조하는 단계와, 제조된 인삼 용액을 100℃ 이상으로 일정 시간 끊이는 단계와, 끊인 인삼 용액의 온도를 80 내지 90℃로 낮추고, 온도를 낮춘 인삼 용액에 상엽 및 오미자 혼합 추출물을 혼합하여 80 내지 90℃로 가열하는 단계와, 감압농축기에서 60℃의 온도로 5배 부피가 감소하게 감압 농축하는 단계를 포함한다.In yet another embodiment, the method for preparing a topical extract comprises the steps of immersing a mixture obtained by mixing a dried top-ground powder and an omija powder at a predetermined ratio in hot water at 50 to 60 ° C for a predetermined time to obtain a mixed extract of hot- Preparing a ginseng solution by adding purified water to ginseng extract powder; breaking the prepared ginseng solution at a temperature of 100 ° C or higher for a predetermined time; lowering the temperature of the ginseng solution to 80 to 90 ° C; Mixing the solution with the upper leaves and the omija mixed extract, heating the mixture to 80 to 90 캜, and concentrating the mixture under reduced pressure to reduce the volume by 5 times at a temperature of 60 캜 in a vacuum concentrator.

감압 농축한 후, 일정 조건의 진공 하에서 동결 건조하거나 일정 온도에서 분무 건조하는 단계를 더 포함한다.Condensation under reduced pressure, freeze-drying under a predetermined condition of vacuum or spray-drying at a constant temperature.

본 발명에서는 일정 시간과 온도로 끊인 인삼 용액에 상엽과 오미자를 첨가하는 방법을 사용하며, 충분한 살균과 상엽이나 오미자 성분의 파괴를 최소화하기 위해 감압 농축하기 전까지 80 내지 90℃를 유지하는 것이 필요하다.In the present invention, the method of adding the top leaves and the omija to the ginseng solution which has been terminated for a predetermined time and temperature is used, and it is necessary to maintain 80 to 90 ° C until sufficient decompression and concentration of the decompression- .

이상에서 설명한 본 발명의 실시예는 장치 및/또는 방법을 통해서만 구현이 되는 것은 아니며, 본 발명의 실시예의 구성에 대응하는 기능을 실현하기 위한 프로그램, 그 프로그램이 기록된 기록 매체 등을 통해 구현될 수도 있으며, 이러한 구현은 앞서 설명한 실시예의 기재로부터 본 발명이 속하는 기술분야의 전문가라면 쉽게 구현할 수 있는 것이다.The embodiments of the present invention described above are not implemented only by the apparatus and / or method, but may be implemented through a program for realizing functions corresponding to the configuration of the embodiment of the present invention, a recording medium on which the program is recorded And such an embodiment can be easily implemented by those skilled in the art from the description of the embodiments described above.

이상에서 본 발명의 실시예에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고 다음의 청구범위에서 정의하고 있는 본 발명의 기본 개념을 이용한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리범위에 속하는 것이다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments, It belongs to the scope of right.

Claims (6)

추출기에 물 70 리터를 넣고 50℃로 가열하는 단계;
일정량의 건조된 상엽을 추출포에 넣고 추출기에 투입하여 50℃에서 4시간 동안 추출하고 1㎛ 여과막에서 여과시키는 단계;
감압농축기에서 60℃의 온도로 6배 부피가 감소하게 감압 농축하는 단계;
살균기에서 상엽 추출물농축액을 80℃에서 30분간 살균하는 단계; 및
상기 추출한 상엽 추출물농축액을 일정 조건의 진공 하에서 동결 건조하거나 일정 온도에서 분무 건조하는 단계를 포함하는 것을 특징으로 하는 상엽 추출물 제조 방법.
Adding 70 liters of water to the extractor and heating to 50 캜;
A predetermined amount of dried top leaves are put into an extracting bag, put into an extractor, extracted at 50 ° C for 4 hours, and filtered through a 1 μm filter membrane;
Concentrated under reduced pressure in a vacuum concentrator at a temperature of 60 DEG C to reduce the volume by 6 times;
Sterilizing the leaf extract concentrate in a sterilizer at 80 DEG C for 30 minutes; And
Drying the concentrated extract of the leaf extract of the present invention under freeze-drying under a predetermined condition or by spray-drying at a predetermined temperature.
제1항에 있어서,
상기 진공 하에서 동결 건조하거나 일정 온도에서 분무 건조하는 단계는,
상기 동결 건조 단계에 있어서는, 상기 상엽 추출물농축액내 고형분 함량을 기준으로 상기 상엽 추출물농축액 내 고형분 함량 대비 말토덱스트린 함량을 8:2로 배합하여 -40℃, 600 mTorr 이하의 진공 하에서 72시간 동안 동결 건조하고,
상기 분무 건조 단계에 있어서는, 상기 상엽 추출물농축액 내 고형분 함량을 기준으로 상기 상엽 추출물농축액 내 고형분 함량 대비 말토덱스트린 함량을 8:2로 배합하여 240℃에서 분무 건조하는 것을 특징으로 하는 상엽 추출물 제조 방법.
The method according to claim 1,
The step of freeze-drying under vacuum or spray-drying at a predetermined temperature may be carried out,
In the lyophilization step, maltodextrin content was adjusted to 8: 2 based on the solid content in the concentrate of the leaf extract, based on the solid content of the leaf extract, and the mixture was freeze-dried at -40 ° C. under a vacuum of 600 mTorr or less for 72 hours and,
Wherein the maltodextrin content is 8: 2 by weight based on the solid content in the concentrated liquid of the leaf extract, and spray drying is performed at 240 캜.
제1항에 있어서,
상기 동결 건조된 분말시료의 지표 성분 함량은 1-Deoxynojirimycin(DNJ) 함량이 95.39mg/100g이며, 상기 분무 건조된 분말시료의 지표 성분 함량은 1-Deoxynojirimycin(DNJ) 함량이 86.03mg/100g인 것을 특징으로 하는 상엽 추출물 제조 방법.
The method according to claim 1,
The concentration of 1-Deoxynojirimycin (DNJ) in the lyophilized powder sample was 95.39 mg / 100 g, and the content of 1-Deoxynojirimycin (DNJ) in the spray dried powder sample was 86.03 mg / 100 g Wherein the method comprises the steps of:
건조 분쇄한 인삼 분말과 상엽을 1 : 1 내지 3 중량비로 혼합한 혼합물을 추출기에 투입하여 50℃에서 3시간 동안 추출하고 1㎛ 여과막에서 여과시키는 단계;
감압농축기에서 60℃의 온도로 5배 부피가 감소하게 감압 농축하는 단계; 및
살균기에서 추출물농축액을 80℃에서 30분간 살균시키는 단계를 포함하는 것을 특징으로 하는 상엽 추출물 제조 방법.
Mixing the dried and ground ginseng powder with the upper leaves at a weight ratio of 1: 1 to 3: 3, and extracting the mixture at 50 ° C for 3 hours and filtering through a 1 μm filter membrane;
Concentrated under reduced pressure in a vacuum concentrator at a temperature of 60 ° C to reduce the volume by 5 times; And
And sterilizing the extract concentrate in a sterilizer at 80 DEG C for 30 minutes.
제4항에 있어서,
상기 살균하는 단계 이후에,
상기 추출물농축액을 -40℃, 60mTorr 이하의 진공 하에서 72시간 동안 동결 건조시킨 후 분쇄하여 약리분말을 얻는 단계;
오미자를 건조 및 분쇄하여 오미자 분말의 증량제를 얻는 단계;
상기 약리분말과 오미자 분말의 혼합물을 환으로 뭉치거나, 약용캡슐 내에 캡슐레이션하거나 환으로 뭉친 후 그 외면에 약용피막을 입히는 단계를 더 포함하는 것을 특징으로 하는 상엽 추출물 제조 방법.
5. The method of claim 4,
After the sterilization step,
Lyophilizing the extract concentrate for 72 hours under a vacuum of -40 DEG C, 60 mTorr or less, and pulverizing the extract to obtain a pharmacological powder;
Drying and crushing the omiza to obtain an extender of the omija powder;
Further comprising the step of aggregating the mixture of the pharmacological powder and the omija powder into a ring, encapsulating the mixture in a capsule for medicines or a ring, and applying a medicinal coating on the outer surface of the capsule.
제4항에 있어서,
상기 감압 농축하는 단계 이후에,
상기 감압 농축된 추출물농축액과 오미자 분말을 1:0.5 내지 1 중량비로 혼합하여 혼합물을 생성하는 단계;
상기 혼합물과 설탕을 1:0.5 내지 1 중량비로 혼합한 후, 24시간 동안 저어주면서 산을 추출하고 일정 시간 1 내지 10회 섞어준 후 여과하는 단계;
살균기에서 상기 추출물농축액을 60 내지 70℃에서 30분간 중탕하여 살균시키는 단계를 더 포함하는 것을 특징으로 하는 상엽 추출물 제조 방법.
5. The method of claim 4,
After the step of concentration under reduced pressure,
Mixing the extract concentrate with the reduced-pressure concentrated extract and Omija powder at a weight ratio of 1: 0.5 to 1 to produce a mixture;
Mixing the mixture with the sugar at a weight ratio of 1: 0.5 to 1, then extracting the acid with stirring for 24 hours, mixing the mixture for 1 to 10 times, and then filtering the mixture;
Further comprising the step of sterilizing the extract concentrate in a sterilizer at 60 to 70 DEG C for 30 minutes with stirring.
KR1020160157981A 2016-11-25 2016-11-25 Method for Preparing Mulberry Leaf Extracts KR101894994B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160157981A KR101894994B1 (en) 2016-11-25 2016-11-25 Method for Preparing Mulberry Leaf Extracts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160157981A KR101894994B1 (en) 2016-11-25 2016-11-25 Method for Preparing Mulberry Leaf Extracts

Publications (2)

Publication Number Publication Date
KR20180063390A true KR20180063390A (en) 2018-06-12
KR101894994B1 KR101894994B1 (en) 2018-09-05

Family

ID=62622181

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160157981A KR101894994B1 (en) 2016-11-25 2016-11-25 Method for Preparing Mulberry Leaf Extracts

Country Status (1)

Country Link
KR (1) KR101894994B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021156184A1 (en) * 2020-02-07 2021-08-12 Dsm Ip Assets B.V. New formulation of a plant extract
CN114557449A (en) * 2021-08-13 2022-05-31 西安诺众康健生物科技有限责任公司 Mulberry leaf and ginseng composite extract and preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040054923A (en) * 2002-12-18 2004-06-26 충청남도 Manufacturing Method of Mulberry Tea Composition
KR20140026748A (en) * 2012-08-23 2014-03-06 재단법인 금산국제인삼약초연구소 An anti-diabetes composition comprising ginseng radix and mulberry tree extract as effective ingredients
KR20160035152A (en) * 2014-09-22 2016-03-31 충북대학교 산학협력단 Method of Preparing Mulberry Leaves Extract Enriched with Biologically Active Substances

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040054923A (en) * 2002-12-18 2004-06-26 충청남도 Manufacturing Method of Mulberry Tea Composition
KR20140026748A (en) * 2012-08-23 2014-03-06 재단법인 금산국제인삼약초연구소 An anti-diabetes composition comprising ginseng radix and mulberry tree extract as effective ingredients
KR20160035152A (en) * 2014-09-22 2016-03-31 충북대학교 산학협력단 Method of Preparing Mulberry Leaves Extract Enriched with Biologically Active Substances

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021156184A1 (en) * 2020-02-07 2021-08-12 Dsm Ip Assets B.V. New formulation of a plant extract
CN114557449A (en) * 2021-08-13 2022-05-31 西安诺众康健生物科技有限责任公司 Mulberry leaf and ginseng composite extract and preparation method and application thereof

Also Published As

Publication number Publication date
KR101894994B1 (en) 2018-09-05

Similar Documents

Publication Publication Date Title
KR20070111623A (en) Pharmaceutical composition for treating or preventing diabetic complication containing an extract of chinese herb as an effective ingredient
CN102217686A (en) Hypoglycemic tea and preparation method thereof
KR20070118754A (en) Pharmaceutical composition for treating or preventing diabetes mellitus containing an extract of chinese herb as an effective ingredient
CN105918743A (en) Sugarfree inonotuso bliquus(Fr )Pilat health-care beverage and making method thereof
KR101060309B1 (en) Restorative herb medicine with jujube and manufacturing method thereof
KR101894994B1 (en) Method for Preparing Mulberry Leaf Extracts
KR101834745B1 (en) A manufacturing method of functional powder comprising abundant rutin ingredient
KR102150162B1 (en) Liquid composition for stick-type container comprising active mountain-cultivated ginseng extract having increased ginsenosides of human body absorption type, and preparation method thereof
KR101774769B1 (en) Composition for medicinal herbal tea and manufacturing method of composition for medicinal herbal by supercritical fluid extraction and manufacturing method of carbonated beverage and health beverage thereof
CN108651786A (en) A kind of preparation method of full nutritional sea buckthorn fruit juice
CN107417696A (en) A kind of method that raspberry glycosides and ellagic acid are extracted from raspberry
KR101376794B1 (en) Cynanchum wilfordii tea and manufacturing method thereof
EP2240191A2 (en) Composition comprising the extracts of lysimachia clethroides for prevention and treatment of cardiovascular diseases
CN108042661B (en) White tea extract rich in dihydromyricetin and application thereof in preparing medical health products
CN103283896A (en) Preparation method of Eucommia Ulmoides Oliver staminate flower tea
KR101894991B1 (en) Method for Preparing Mulberry Extracts
KR101929664B1 (en) Fermented-white ginseng extracts containing increased ginsenoside Rd, Rg3 and Rg5 and method thereof
CN106692257B (en) A kind of combination of pectins, preparation method and its usage
KR101648211B1 (en) Sasa quelpaertensis nakai tea and manufacture method thereof
CN111944009B (en) Preparation method and application of salicornia bigelovii antihypertensive peptide
CN108686012A (en) A kind of the membrane of a chicken's gizzard preparation and preparation method thereof
CN107647074A (en) A kind of nourishing the stomach, stomach invigorating, the preparation method of dyspepsia hawthorn Chinese yam Hericium erinaceus pressed candy
CN109053849A (en) The method of Fructus Corni comprehensive utilization
CN108925807A (en) A kind of solid beverage and preparation method thereof of hypoglycemic decompression
KR20090078013A (en) Blood glucose dropping mulberry leaf tea cultured with phellinus linteus mycelium

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant